首页> 外文OA文献 >Induction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain
【2h】

Induction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain

机译:重组枯草芽孢杆菌菌株产生的变异链球菌P1蛋白氨基末端多肽免疫的小鼠中和抗体的诱导

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The oral pathogen Streptococcus mutans expresses a surface protein, P1, which interacts with the salivary pellicle on the tooth surface or with fluid-phase saliva, resulting in bacterial adhesion or aggregation, respectively. P1 is a target of protective immunity. Its N-terminal region has been associated with adhesion and aggregation functions and contains epitopes recognized by efficacious antibodies. In this study, we used Bacillus subtilis, a gram-positive expression host, to produce a recombinant N-terminal polypeptide of P1 (P1(39-512)) derived from the S. mutans strain UA159. Purified P1(39-512) reacted with an anti-full-length P1 antiserum as well as one raised against intact S. mutans cells, indicating preserved antigenicity. Immunization of mice with soluble and heat-denatured P1(39-512) induced antibodies that reacted specifically with native P1 on the surface of S. mutans cells. The anti-P1(39-512) antiserum was as effective at blocking saliva-mediated aggregation of S. mutans cells and better at blocking bacterial adhesion to saliva-coated plastic surfaces compared with the anti-full-length P1 antiserum. In addition, adsorption of the anti-P1 antiserum with P1(39-512) eliminated its ability to block the adhesion of S. mutans cells to abiotic surfaces. The present results indicate that P1(39-512), expressed and purified from a recombinant B. subtilis strain, maintains important immunological features of the native protein and represents an additional tool for the development of anticaries vaccines.
机译:口腔病原体变形链球菌表达一种表面蛋白P1,该蛋白与牙齿表面的唾液薄膜或液相唾液相互作用,分别导致细菌粘附或聚集。 P1是保护性免疫的目标。它的N端区域已与粘附和聚集功能相关联,并包含有效抗体识别的表位。在这项研究中,我们使用了枯草芽孢杆菌(一种革兰氏阳性表达宿主)来生产衍生自变形链球菌菌株UA159的P1的重组N末端多肽(P1(39-512))。纯化的P1(39-512)与抗全长P1抗血清以及针对完整变形链球菌细胞产生的抗血清反应,表明抗原性得以保留。用可溶性和热变性的P1(39-512)诱导的小鼠免疫,该抗体与变形链球菌细胞表面的天然P1特异性反应。与抗全长P1抗血清相比,抗P1(39-512)抗血清在阻止唾液介导的变形链球菌细胞聚集方面效果更好,在阻断细菌对唾液涂层塑料表面的粘附方面效果更好。此外,抗P1抗血清与P1(39-512)的吸附消除了其阻止变形链球菌细胞粘附于非生物表面的能力。本结果表明,从重组枯草芽孢杆菌菌株表达和纯化的P1(39-512)保持了天然蛋白质的重要​​免疫学特征,并代表了开发抗龋疫苗的另一种工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号